Evaluation of melphalan, ICRF-159, and hydroxyurea in metastatic prostate cancer: a preliminary report.
D000230:Adenocarcinoma / Q000188:drug therapy*; D000368:Aged; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D008297:Male; D008558:Melphalan / Q000627:therapeutic use*; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010879:Piperazines / Q000627:therapeutic use*; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D011929:Razoxane / Q000627:therapeutic use*
D010879:Piperazines; D011929:Razoxane; D008558:Melphalan; D006918:Hydroxyurea